Page last updated: 2024-11-05

tizanidine and Takotsubo Cardiomyopathy

tizanidine has been researched along with Takotsubo Cardiomyopathy in 1 studies

tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.

Takotsubo Cardiomyopathy: A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.

Research Excerpts

ExcerptRelevanceReference
" The drug should be gradually reduced in dosage under observation by a psychiatrist."1.42[Tizanidine withdrawal symptoms in stress cardiomyopathy]. ( Bayer, D; Bengesser, SA; Kapfhammer, HP; Mörkl, S; Schöggl, H, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mörkl, S1
Bengesser, SA1
Schöggl, H1
Bayer, D1
Kapfhammer, HP1

Other Studies

1 other study available for tizanidine and Takotsubo Cardiomyopathy

ArticleYear
[Tizanidine withdrawal symptoms in stress cardiomyopathy].
    Fortschritte der Neurologie-Psychiatrie, 2015, Volume: 83, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Clonidine; Electrocardiography; Humans; Male; Middle Aged; Mus

2015